Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LRP in Alzheimer’s disease: friend or foe?
Paula G. Ulery, Dudley K. Strickland
Paula G. Ulery, Dudley K. Strickland
Published November 1, 2000
Citation Information: J Clin Invest. 2000;106(9):1077-1079. https://doi.org/10.1172/JCI11455.
View: Text | PDF
Commentary

LRP in Alzheimer’s disease: friend or foe?

  • Text
  • PDF
Abstract

Authors

Paula G. Ulery, Dudley K. Strickland

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Proposed dual role of LRP in Aβ metabolism. Association of Aβ with LRP l...
Proposed dual role of LRP in Aβ metabolism. Association of Aβ with LRP ligands (apoE, α2M*, or lactoferrin) results in rapid LRP-mediated endocytosis of the complex. On the other hand, association of APP isoforms containing KPI domains (APPKPI) leads to increased Aβ generation and deposition. In AD, the catabolic pathway may be impaired by decreased levels of LRP at clearance sites (perhaps neurons or sites along the capillary membranes), while Aβ generation may be enhanced by upregulation of LRP in activated glia found in the AD brain.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts